COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Mar. 31, 2014
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 5: - COMMITMENTS AND CONTINGENCIES Commitments and contingencies that changed during the nine months ended March 31, 2014, include the following: Increase in the amount of $3,292 of cash pledged by the Company to secure its hedging transactions, credit line and bank guarantees. The Company, through its Israeli subsidiary, participated in programs sponsored by the Israeli Government for the support of research and development activities. Through March 31, 2014, the Company had obtained grants from the Office of the Chief Scientist ("OCS") aggregating to approximately $14,156 of its research and development projects. The Company is obligated to pay royalties to the OCS, amounting to 3%-4% of the sales of the products and other related revenues generated from such projects, up to 100% of the grants received, linked to the U.S. dollars and for grants received after January 1, 1999, also bearing interest at the rate of LIBOR. The obligation to pay these royalties is contingent on actual revenues and in the absence of such revenues, no payment is required. Through March 31, 2014, the Company has paid or accrued royalties to the OCS in the amount of $50. As of March 31, 2014, the aggregate contingent liability to the OCS amounted to $14,106.

The entire disclosure for commitments and contingencies.